Pathologic complete response after presurgery chemotherapy increases overall survival

[News]

Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall survival compared with those who had more than minimal residual invasive disease at surgery following presurgery chemotherapy, according to results from the randomized phase II CALGB/Alliance 40603 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.

More... (http://www.news-medical.net/news/20151211/Pathologic-complete-response-after-presurgery-chemotherapy-increases-overall-survival-for-TNBC-patients.aspx)